Alveolar Soft Part Sarcoma is a Candidate for Therapy by Drugs that Specifically Inhibit the MET Receptor Tyrosine Kinase

by Yosef
April 4, 2007

Alveolar Soft Part Sarcoma is a Candidate for Therapy by Drugs that Specifically Inhibit the MET Receptor Tyrosine Kinase

A collaboration between scientists from The Memorial Sloan-Kettering Cancer Center in New York, Dana-Farber Cancer Institute […]
0
read more
by Yosef
January 31, 2007

Two Sorafenib (Nexavar) Clinical Trials are Currently Recruiting Sarcoma Patients in Different Locations Across the USA

1. Phase II Study of Sorafenib in Patients With Advanced Soft Tissue Sarcomas 2. Sorafenib in […]
0
read more
by Yosef
October 11, 2006

Update on the Clinical Trial for Alveolar Soft Part Sarcoma at the Dana Farber Cancer Institute in Boston

October 11, 2006 The clinical trial “GVAX Cancer Vaccine” started in January 2006 and enrollment is […]
0
read more